Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Iceland-based Actavis Mid-Atlantic, an international generic pharmaceutical company, was asked by a Travis County jury to pay $170.3m to the state of Texas for defrauding Medicaid.
Subscribe to our email newsletter
The court found Actavis and co-defendant Actavis Elizabeth to have misrepresented its drug prices to Medicaid.
The decision came after Florida-based pharmacy Ven-a-Care filed a whistleblower lawsuit under seal against Actavis.
The pharmacy owners said Actavis had reported artificially inflated prices to Medicaid for its drugs.